Effects of n-3 polyunsaturated fatty acid supplementation on appetite: a systematic review and meta-analysis of controlled clinical trials
- PMID: 38281014
- PMCID: PMC10821539
- DOI: 10.1186/s13643-023-02430-y
Effects of n-3 polyunsaturated fatty acid supplementation on appetite: a systematic review and meta-analysis of controlled clinical trials
Abstract
Background: The current studies explore the effect of omega-3 polyunsaturated fatty acids (PUFAs) on appetite.
Objective: To examine the effect of omega-3 polyunsaturated fatty acids (n-3 PUFAs) on appetite using a systematic review and meta-analysis of controlled clinical trials (CTs).
Patients and methods: Online databases including PubMed, Scopus, ISI Web of Science, and Google Scholar were searched up to January 2022. A random-effects model was used to compare the overall standardized mean difference in appetite scores between n-3 PUFAs supplemented and control individuals.
Results: Fifteen eligible CTs with 1504 participants (872 for n-3 PUFA supplementation and 632 for placebo groups) were included in our systematic review. The meta-analysis showed no significant difference in overall appetite score between n-3 PUFAs supplemented and control groups (standardized mean difference [SMD] = 0.458, 95% confidence interval [CI] - 0.327, 1.242, P value = 0.25). However, the n-3 PUFA supplementation significantly increased the desire to eat (SMD = 1.07, 95% CI 0.116, 2.029, P = 0.02) compared to control.
Conclusion: Although we found no effect of omega-3 supplementation on overall appetite score, it modestly increases the desire to eat. Further CTs evaluating the effect of PUFAs on appetite are still needed to confirm these findings.
Keywords: Appetite; Meta-analysis; Systematic review; Visual analog scale; n-3 polyunsaturated fatty acids.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD007986. doi: 10.1002/14651858.CD007986.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2023 Apr 14;4:CD007986. doi: 10.1002/14651858.CD007986.pub3. PMID: 22786509 Free PMC article. Updated.
-
Omega-3 fatty acids for the treatment of dementia.Cochrane Database Syst Rev. 2016 Apr 11;4(4):CD009002. doi: 10.1002/14651858.CD009002.pub3. Cochrane Database Syst Rev. 2016. PMID: 27063583 Free PMC article.
-
Omega-3 fatty acid supplementation for depression in children and adolescents.Cochrane Database Syst Rev. 2024 Nov 20;11(11):CD014803. doi: 10.1002/14651858.CD014803.pub2. Cochrane Database Syst Rev. 2024. PMID: 39564892
-
Omega-3 fatty acids for depression in adults.Cochrane Database Syst Rev. 2021 Nov 24;11(11):CD004692. doi: 10.1002/14651858.CD004692.pub5. Cochrane Database Syst Rev. 2021. PMID: 34817851 Free PMC article.
-
Omega-3 fatty acids for depression in adults.Cochrane Database Syst Rev. 2015 Nov 5;2015(11):CD004692. doi: 10.1002/14651858.CD004692.pub4. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Nov 24;11:CD004692. doi: 10.1002/14651858.CD004692.pub5. PMID: 26537796 Free PMC article. Updated.
Cited by
-
Polyunsaturated fatty acids promote appetite via the microbiome-gut-brain axis.bioRxiv [Preprint]. 2025 Jul 29:2025.07.29.667447. doi: 10.1101/2025.07.29.667447. bioRxiv. 2025. PMID: 40766454 Free PMC article. Preprint.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials